Concurrent Investment Advisors LLC boosted its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 63.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 67,648 shares of the financial services provider's stock after buying an additional 26,282 shares during the period. Concurrent Investment Advisors LLC's holdings in Aflac were worth $7,460,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also bought and sold shares of the company. TKG Advisors LLC lifted its position in shares of Aflac by 1.3% during the fourth quarter. TKG Advisors LLC now owns 23,210 shares of the financial services provider's stock worth $2,559,000 after acquiring an additional 292 shares in the last quarter. AGP Franklin LLC grew its position in shares of Aflac by 2.8% in the fourth quarter. AGP Franklin LLC now owns 18,779 shares of the financial services provider's stock valued at $2,071,000 after purchasing an additional 503 shares in the last quarter. Diversified Enterprises LLC bought a new stake in shares of Aflac during the 4th quarter valued at $226,000. Sage Private Wealth Group LLC lifted its holdings in Aflac by 3.1% during the 4th quarter. Sage Private Wealth Group LLC now owns 4,981 shares of the financial services provider's stock worth $549,000 after purchasing an additional 148 shares in the last quarter. Finally, Turtle Creek Wealth Advisors LLC lifted its holdings in Aflac by 10.8% during the 4th quarter. Turtle Creek Wealth Advisors LLC now owns 77,708 shares of the financial services provider's stock worth $8,569,000 after purchasing an additional 7,580 shares in the last quarter. Institutional investors own 67.44% of the company's stock.
Aflac Stock Up 0.1%
AFL stock opened at $114.71 on Monday. The company's 50 day moving average is $111.29 and its 200 day moving average is $110.72. The stock has a market cap of $59.09 billion, a price-to-earnings ratio of 16.67, a price-to-earnings-growth ratio of 3.14 and a beta of 0.66. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1-year low of $96.95 and a 1-year high of $119.32.
Aflac (NYSE:AFL - Get Free Report) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $1.57 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.12). Aflac had a net margin of 21.24% and a return on equity of 14.35%. The company had revenue of $4.28 billion for the quarter, compared to the consensus estimate of $4.45 billion. During the same quarter in the previous year, the firm earned $1.57 earnings per share. The company's revenue for the quarter was down 9.6% compared to the same quarter last year. Sell-side analysts predict that Aflac Incorporated will post 7.28 EPS for the current fiscal year.
Insider Buying and Selling at Aflac
In other news, major shareholder Post Holdings Co. Ltd. Japan sold 86,155 shares of Aflac stock in a transaction on Thursday, April 9th. The shares were sold at an average price of $113.24, for a total transaction of $9,756,192.20. Following the completion of the sale, the insider directly owned 51,636,945 shares of the company's stock, valued at approximately $5,847,367,651.80. The trade was a 0.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 572,632 shares of company stock worth $63,514,634. Company insiders own 0.80% of the company's stock.
Analyst Upgrades and Downgrades
AFL has been the subject of a number of recent analyst reports. Keefe, Bruyette & Woods lifted their target price on Aflac from $113.00 to $115.00 and gave the company a "market perform" rating in a report on Friday, April 10th. Barclays set a $101.00 price target on shares of Aflac and gave the stock an "underweight" rating in a report on Thursday, January 8th. Raymond James Financial reaffirmed an "outperform" rating and set a $119.00 price objective (up from $110.00) on shares of Aflac in a research note on Tuesday, December 30th. Wells Fargo & Company decreased their target price on shares of Aflac from $118.00 to $116.00 and set an "equal weight" rating on the stock in a report on Friday, April 10th. Finally, Mizuho set a $102.00 price target on shares of Aflac and gave the company an "underperform" rating in a report on Monday, April 13th. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $111.82.
Get Our Latest Stock Report on AFL
About Aflac
(
Free Report)
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac's product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.